193 related articles for article (PubMed ID: 32037744)
1. Effect of Diquafosol on Hyperosmotic Stress-induced Tumor Necrosis Factor-α and Interleukin-6 Expression in Human Corneal Epithelial Cells.
Kim YH; Yang IJ; Nguyen LTH; Gum SI; Yu S; Lee GJ; Kim BA; Jung JC; Park YJ
Korean J Ophthalmol; 2020 Feb; 34(1):1-10. PubMed ID: 32037744
[TBL] [Abstract][Full Text] [Related]
2. Diquafosol promotes corneal epithelial healing via intracellular calcium-mediated ERK activation.
Byun YS; Yoo YS; Kwon JY; Joo JS; Lim SA; Whang WJ; Mok JW; Choi JS; Joo CK
Exp Eye Res; 2016 Feb; 143():89-97. PubMed ID: 26505315
[TBL] [Abstract][Full Text] [Related]
3. Diquafosol Sodium Inhibits Apoptosis and Inflammation of Corneal Epithelial Cells Via Activation of Erk1/2 and RSK: In Vitro and In Vivo Dry Eye Model.
Park JH; Moon SH; Kang DH; Um HJ; Kang SS; Kim JY; Tchah H
Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):5108-5115. PubMed ID: 30372737
[TBL] [Abstract][Full Text] [Related]
4. Diquafosol ophthalmic solution enhances mucin expression via ERK activation in human conjunctival epithelial cells with hyperosmotic stress.
Lee HJ; Yang S; Cheon EJ; Shin S; Byun YS; Kim HS; Chung SH
Mol Vis; 2022; 28():114-123. PubMed ID: 36034736
[TBL] [Abstract][Full Text] [Related]
5. Conjunctival expression of the P2Y2 receptor and the effects of 3% diquafosol ophthalmic solution in dogs.
Terakado K; Yogo T; Kohara Y; Soeta S; Nezu Y; Harada Y; Hara Y; Amasaki H; Tagawa M
Vet J; 2014 Oct; 202(1):48-52. PubMed ID: 25178686
[TBL] [Abstract][Full Text] [Related]
6. The effects of 3% diquafosol sodium application on the tear functions and ocular surface of the Cu,Zn-superoxide dismutase-1 (Sod1)-knockout mice.
Kojima T; Dogru M; Ibrahim OM; Nagata T; Higa K; Shimizu T; Shirasawa T; Satake Y; Shimazaki S; Shimazaki J; Tsubota K
Mol Vis; 2014; 20():929-38. PubMed ID: 24991185
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Ocular Surface Mucin Expression After Topical Ophthalmic Drug Administration in Dry Eye-Induced Mouse Model.
Moon I; Kang HG; Yeo A; Noh H; Kim HC; Song JS; Ji YW; Lee HK
J Ocul Pharmacol Ther; 2018 Nov; 34(9):612-620. PubMed ID: 30325678
[TBL] [Abstract][Full Text] [Related]
8. Significance of ectodomain shedding of TNF receptor 1 in ocular surface.
Sakimoto T; Ohnishi T; Ishimori A
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2419-23. PubMed ID: 24627147
[TBL] [Abstract][Full Text] [Related]
9. Reactive oxygen species activated NLRP3 inflammasomes initiate inflammation in hyperosmolarity stressed human corneal epithelial cells and environment-induced dry eye patients.
Zheng Q; Ren Y; Reinach PS; Xiao B; Lu H; Zhu Y; Qu J; Chen W
Exp Eye Res; 2015 May; 134():133-40. PubMed ID: 25701684
[TBL] [Abstract][Full Text] [Related]
10. The effects of 3% diquafosol sodium eye drop application on meibomian gland and ocular surface alterations in the Cu, Zn-superoxide dismutase-1 (Sod1) knockout mice.
Ikeda K; Simsek C; Kojima T; Higa K; Kawashima M; Dogru M; Shimizu T; Tsubota K; Shimazaki J
Graefes Arch Clin Exp Ophthalmol; 2018 Apr; 256(4):739-750. PubMed ID: 29484560
[TBL] [Abstract][Full Text] [Related]
11. Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye.
Tauber J; Davitt WF; Bokosky JE; Nichols KK; Yerxa BR; Schaberg AE; LaVange LM; Mills-Wilson MC; Kellerman DJ
Cornea; 2004 Nov; 23(8):784-92. PubMed ID: 15502479
[TBL] [Abstract][Full Text] [Related]
12. Imbalanced IL-37/TNF-α/CTSS signaling disrupts corneal epithelial barrier in a dry eye model in vitro.
Zhang Y; Li JM; Lu R; Liu Z; Chen X; de Paiva CS; Pflugfelder SC; Li DQ
Ocul Surf; 2022 Oct; 26():234-243. PubMed ID: 36208723
[TBL] [Abstract][Full Text] [Related]
13. Trehalose Induces Autophagy Against Inflammation by Activating TFEB Signaling Pathway in Human Corneal Epithelial Cells Exposed to Hyperosmotic Stress.
Liu Z; Chen D; Chen X; Bian F; Qin W; Gao N; Xiao Y; Li J; Pflugfelder SC; Li DQ
Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):26. PubMed ID: 32785678
[TBL] [Abstract][Full Text] [Related]
14. Changes in Tear Volume after 3% Diquafosol Treatment in Patients with Dry Eye Syndrome: An Anterior Segment Spectral-domain Optical Coherence Tomography Study.
Lee KB; Koh KM; Kwon YA; Song SW; Kim BY; Chung JL
Korean J Ophthalmol; 2017 Aug; 31(4):306-312. PubMed ID: 28752695
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial.
Matsumoto Y; Ohashi Y; Watanabe H; Tsubota K;
Ophthalmology; 2012 Oct; 119(10):1954-60. PubMed ID: 22739038
[TBL] [Abstract][Full Text] [Related]
16. Curcumin protects against hyperosmoticity-induced IL-1beta elevation in human corneal epithelial cell via MAPK pathways.
Chen M; Hu DN; Pan Z; Lu CW; Xue CY; Aass I
Exp Eye Res; 2010 Mar; 90(3):437-43. PubMed ID: 20026325
[TBL] [Abstract][Full Text] [Related]
17. Effects of L-carnitine, erythritol and betaine on pro-inflammatory markers in primary human corneal epithelial cells exposed to hyperosmotic stress.
Hua X; Su Z; Deng R; Lin J; Li DQ; Pflugfelder SC
Curr Eye Res; 2015 Jul; 40(7):657-67. PubMed ID: 25271595
[TBL] [Abstract][Full Text] [Related]
18. 17-β-estradiol inhibits hyperosmolarity-induced proinflammatory cytokine elevation via the p38 MAPK pathway in human corneal epithelial cells.
Wang C; Shi X; Chen X; Wu H; Zhang H; Xie J; Yang X; Gou Z; Ye J
Mol Vis; 2012; 18():1115-22. PubMed ID: 22605923
[TBL] [Abstract][Full Text] [Related]
19. Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren's syndrome.
Yokoi N; Sonomura Y; Kato H; Komuro A; Kinoshita S
Eye (Lond); 2015 Sep; 29(9):1204-12. PubMed ID: 26160526
[TBL] [Abstract][Full Text] [Related]
20. Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition.
Shigeyasu C; Yamada M; Akune Y; Tsubota K
Jpn J Ophthalmol; 2015 Nov; 59(6):415-20. PubMed ID: 26310103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
